Summary
A comparison of cardiovascular drug sales and cardiovascular mortality was made between two Swedish counties (Värmland and Malmöhus) and between two rural municipalities in those counties (Torsby in Värmland and Hörby in Malmöhus).
Cardiovascular drug sales (defined daily doses (DDD) per 1,000 inhabitants per day) during 1986–87 were 25 higher in Vdrmland than in Malmöhus county, and the age-standardized mortality of coronary heart disease (CHD) was 36% (men) and 54% (women) higher. In Torsby, age-standardized CHD mortality (1986–87) was 71 % (both sexes) higher than in H6rby, and the sales of cardiovascular drugs (1978–87) were 58 % higher. Statistically, every third inhabitant of Torsby took one DDD of a cardiovascular drug every day, as compared to every fifth inhabitant in Hörby. In Torsby there was a 6 % higher serum cholesterol, 71 % lower tap water hardness, 33 lower income, a lower educational level, a three-fold higher unemployment rate, and a different ethnic background (20 % eastern Finnish ancestry), all factors assumed to promote a high CHD rate.
All of these factors may contribute to the higher CHD mortality, which was in turn reflected in higher sales of cardiovascular drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bergman U (1978) Utilization of antidiabetic drugs in the island of Gotland, Sweden. Agreement between wholesale figures and prescription data. Ent J Clin Pharmacol 14: 213–220
Swedish Statistics on Drugs (1991) The National Corporation of Pharmacies, Stockholm, Sweden
Mölstad S, Hovelius B, Kroon L, Melander A (1990) Prescription of antibiotics to outpatients in hospital clinics, community health centres and private practice. Eur J Clin Pharmacol 39: 9–12
Wessling A, Bergman U, Westerholm B (1991) On the difference in psychotropic drug use between the three major urban areas in Sweden. Eur J Clin Pharmacol 40: 495–500
Melander A, Henricson K, Stenberg P, Löwenhielm P, Malmvik J, Sternebring B, Kaij L, Bergdahl U (1991) Anxiolytic-hypnotic drugs: relations between prescribing, abuse and suicide. Eur J Clin Pharmacol 41: 525–529
Ekedahl A, Lidbeck J, Lithman T, Noreen D, Melander A in press Benzodiazepine prescribing patterns in a high-prescribing Scandinavian community. Eur J Clin Pharmacol
Rosén M (1987) Epidemiology in planning for health. Umeå University medical dissertations. New series No. 188 ISSN 03466612, Umeå, Sweden
Nerbrand C (1990) Cardiovascular diseases in seven counties of Sweden — regional differences and risk factors. Ph. D. Thesis, Uppsala University
Wessling A, Boëthius G (1990) Measurement of drug use in a defined population. Eur J Clin Pharmacol 39: 207–210
Bergman U, Elmes P, Halse M, Halvorsen T, Hood H, Lunde PKM, Sjögvist F, Wade OL, Westerholm B (1975) The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol 8:83–89
Råstam L, Sjönell G (1991) A new device for measurement of blood pressure in adults. Lancet 1: 249–250
Broberg R (1967) Invandringar från Finland till mellersta Skandinavien före 1700 (Immigration from Finland to the middle part of Scandinavia before 1700). Svenska Landsmål och Svenskt Folkliv, Stockholm
Lewis B, Pyörälä K (eds) Lipoproteins and atherosclerosis (1987) Current views, future trends. Eur Heart J 8 [Suppl E]
The Värmland Survey. (1971) Socialstyrelsen redovisar (The Swedish Board of Health and Welfare reports) No. 23. Allmänna Förlaget AB, Stockholm, Sweden
Grundy SM (1986) Cholesterol and coronary heart disease. A new area JAMA 256:2849–2858
Anderson TW, Nevi LC, Schreiber GB, Talbot FDF, Zdrojewski A (1975) Ischemic heart disease, water hardness and myocardial magnesium. Can Med Ass J 113:199–203
Yacowitz H, Fleischman Al, Bierenbaum ML (1965) Effects of oral calcium upon serum lipids in man. Br Med J 1: 1352–1358
Fleischman Al, Yacowitz H, Hayton T, Bierenbaum ML (1966) Effects of dietary calcium upon lipid metabolism in mature male rats feed beef tallow. J Nutr 88:255–260
Davey Smith G, Shipley MJ, Rose G (1990) Magnitude and causes of socioeconomic differentials in mortality: further evidence from the Whitehall Study. J Epid Community Health 44: 265–270
Wilhelmson L, Bengtsson C, Elmfeldt D, Vedin A, Wilhelmson C, Tibblin G, Lindqvist O, Wedel H (1977) Multiple risk prediction of myocardial infarction in women as compared with men. Br Heart J 39:1179–1185
Gotto Jr AM (1988) Coexistent hypercholesterolaemia and hypertension in CHD risk: clinical aspects and considerations. Lipid Rev 3:17–23
Carlsson LA, Böttiger LE (1985) Risk factors for ischemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study. Acta Med Scand 218:207–211
Marmot M, Brunner E (1991) Alcohol and cardiovascular disease: the status of the U-shaped curve. Br Med J 303: 565–568
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Öreberg, M., Jousson, G.G., West, K. et al. Large intercommunity difference in cardiovascular drug consumption: relation to mortality, risk factors and socioeconomic differences. Eur J Clin Pharmacol 43, 449–454 (1992). https://doi.org/10.1007/BF02285084
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02285084